TuHURA Biosciences, Inc.HURAEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
HURA Q4 FY2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
N/A
Net Profit
$-6.8M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.13
TuHURA Biosciences, Inc. Q4 FY2025 Financial Summary
TuHURA Biosciences, Inc. reported revenue of $0 for Q4 FY2025, with a net profit of $-6.8M (down 12.8% YoY) (N/A margin).
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-6.8M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 FY2025 |
TuHURA Biosciences, Inc. Annual Revenue by Year
TuHURA Biosciences, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $0).
TuHURA Biosciences, Inc. Quarterly Revenue & Net Profit History
TuHURA Biosciences, Inc. results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $0 | — | $-6.8M | N/A |
| Q3 FY2025 | $0 | — | $-7.1M | N/A |
| Q2 FY2025 | $0 | — | $-9.5M | N/A |
| Q1 FY2025 | $0 | — | $-6.7M | N/A |
| Q3 FY2024 | $0 | — | $-5.6M | N/A |
| Q1 FY2024 | $0 | — | $-4.8M | N/A |
Income Statement
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Assets | $7.4M | $4.1M | $14.6M | $34.6M | $25.7M | $27.4M |
| Liabilities | $1.5M | $2.4M | $4.8M | $15.2M | $8.9M | $6.4M |
| Equity | $-6.1M | $-2.8M | $9.9M | $19.4M | $16.8M | $20.9M |
Cash Flow
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-3.8M | $-1.9M | $-4.7M | $-6.2M | $-11.1M | $-5.6M |